Selected stroke-expression candidates show uneven agreement across datasets
Source check: Source checked. Not independent scientific confirmation.
Finding: LASSO selected 19 expression candidates in archived stroke samples. Four candidates—SCO2, ARF1, APP and NFE2L2—were reported as elevated in both additional datasets, while the full sets of significant genes differed. This is a retrospective expression association, not validation of a 19-gene diagnostic test or a cell-death mechanism.
Technology: LASSO
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A fitted LASSO classifier selected 19 genes from 30 prefiltered candidates, determining the panel examined in the additional datasets.
- Test and result
- The discovery dataset contains 69 stroke specimens sampled at three post-event times plus 23 control specimens. Additional datasets included 39 stroke/24 control records and 10 stroke/5 control specimens; the latter also has repeated time points.
- Limitation / still unknown
- Repeated specimens are not independent patients. The discovery AUC of 1 is an apparent fit, not external diagnostic performance; additional analyses compare individual gene expression and ROC curves rather than a frozen combined panel. Screening, time-point and batch effects limit inference. The genes came from a previously defined pathway list, and no new causal role, biological subtype or clinical utility is established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11408831/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary data/LASSO Methods and external expression Results; primary GEO study metadata; no operational laboratory procedures reviewed.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 1/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.